Lower CSF Amyloid Beta Peptides and Higher F2-Isoprostanes in Cognitively Intact Elderly Individuals With Major Depressive Disorder
Nunzio Pomara, M.D.; Davide Bruno, Ph.D.; Antero S. Sarreal, M.D.; Raymundo T. Hernando, M.D.; Jay Nierenberg, M.D., Ph.D.; Eva Petkova, Ph.D.; John J. Sidtis, Ph.D.; Thomas M. Wisniewski, M.D.; Pankaj D. Mehta, Ph.D.; Domenico Pratico, M.D.; Henrik Zetterberg, M.D., Ph.D.; Kaj Blennow, M.D., Ph.D.
From the Nathan Kline Institute, Orangeburg, N.Y.; New York University School of Medicine, New York; New York State Institute for Basic Research, Staten Island, N.Y.; Department of Pharmacology, Temple University, Philadelphia; and Neurochemistry Lab, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Am J Psychiatry 2012;169:523-530.
doi:10.1176/appi.ajp.2011.11081153
Purchase Online access to this article for 24 hours
Clicking on the buy now link will redirect you to the shopping cart at APPI.org where you will be asked to log in or create an account to complete your transaction. Once your transaction is complete, you will receive an email with instructions for accessing this content online and in PDF format.
You may view, download, and/or print the article for your personal, scholarly, research, and educational use. You may not (i) distribute a copy
(electronic or otherwise) of the article without the written permission of APA, (ii) post the article on an electronic bulletin board or web
site, or (iii) charge for a copy (electronic or otherwise) of the article.